CD19 and COVID-19: Figure 1A shows the topological distributions of immune cell subpopulations based on different surface antigen expression patterns for healthy controls and COVID-19 patients, respectively. While the data imply ample variation for the abundance of CD19+ and CD177+ populations between both groups, the differences regarding CD3+ and CD14+ populations were less prominent.